Nouvelles & Évènements
- Tout
- Prix
- Communauté
- Profil du Réseau
- Communiqué de presse
- Points saillants de la recherche
Preventing a comeback
GlycoNet researchers work to limit the spreads of tuberculosis
Five research superwomen from GlycoNet you need to know
In honor of International Women’s Day, we introduce you to five GlycoNet scientists who are working to build a healthier Canada.
How a carbohydrate-derived dietary supplement could treat muscular dystrophy
GlycoNet researchers identified a natural supplement that could boost muscle fiber formation.
Le CQDM s’associe à GlycoNet afin de faire progresser la recherche dans le domaine de la glycomique au Canada
The partnership will support the development of novel technologies in drug discovery, accelerate scientific talents across Canada, and advance Canada’s position as an international leader for healthcare innovation.
API partners with GlycoNet to build innovation and commercialization opportunities across Canada
The partnership will significantly enrich GlycoNet’s and API’s capacities to support companies with innovations in glycomics.
How sugar mimics could help enhance the effectiveness of antitumor antibodies
GlycoNet researchers at Simon Fraser University are developing new molecules with the ultimate goal to improve the effectiveness of antitumor antibodies.
A non-opioid pain relief
GlycoNet Investigator is developing a gel-based drug delivery system with a massive potential.
2019: Top 10 Research Advances from GlycoNet Investigators
As the new year approaches, here is a look back at some of the most exciting advances from GlycoNet researchers in 2019.
A tug-of-war in your immune system
GlycoNet Investigators are looking into using carbohydrate-binding proteins to help battle fungal pathogens.
Unlocking the door to potential therapeutic treatments for serious complications from infections
GlycoNet scientists solved the structure of an enzyme that could help burn victims and prevent deaths from different kinds of infections.
How a protein in your brain could protect against Alzheimer’s disease
GlycoNet Investigator sets the stage for new therapeutic strategies for Alzheimer’s disease.
Potent antimicrobial found that shows promise in fighting staph infections
GlycoNet researchers discovered a molecule against Methicillin-resistant (MRSA) bacteria.
French 
English